Latest Breaking News On - Muthusamy shanmugam - Page 6 : comparemela.com

ANI Pharmaceuticals, Inc (NASDAQ:ANIP) COO Muthusamy Shanmugam Sells 6,242 Shares

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) COO Muthusamy Shanmugam sold 6,242 shares of ANI Pharmaceuticals stock in a transaction dated Wednesday, October 18th. The shares were sold at an average price of $57.78, for a total transaction of $360,662.76. Following the transaction, the chief operating officer now owns 1,042,620 shares of the company’s […]

United statesNova scotiaMuthusamy shanmugamPharmaceuticals dailySecurities exchange commissionBlackrock incPharmaceuticals stock performanceWilliam blair investment managementPharmaceuticals company profileDimensional fund advisorsAni pharmaceuticals incVanguard group incPharmaceuticals incGet free reportExchange commissionCapital management

BTC Capital Management Inc Acquires 693 Shares of ANI Pharmaceuticals, Inc (NASDAQ:ANIP)

BTC Capital Management Inc. grew its holdings in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) by 10.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,337 shares of the specialty pharmaceutical company’s stock after purchasing an additional 693 shares during the […]

United statesMuthusamy shanmugamZurcher kantonalbank zurich cantonalbankExchange commissionLazard asset managementSecurities exchange commissionPharmaceuticals incRidgewood investmentsBtc capital management incPharmaceuticals dailyPharmaceuticals price performanceCapital management incFree reportAsset managementKantonalbank zurich cantonalbankSystematic financial management

ANI Pharmaceuticals (NASDAQ:ANIP) Rating Reiterated by Truist Financial

ANI Pharmaceuticals (NASDAQ:ANIP) Rating Reiterated by Truist Financial
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United statesMuthusamy shanmugamPharmaceuticals incOregon public employees retirement fundPharmaceuticals price performanceCharles schwab investment management incPharmaceuticals dailySecurities exchange commissionTruist financialFree reportModerate buyGet free reportExchange commissionRetirement systemPublic employees retirement fundCharles schwab investment management

HC Wainwright Raises ANI Pharmaceuticals (NASDAQ:ANIP) Price Target to $73 00

HC Wainwright Raises ANI Pharmaceuticals (NASDAQ:ANIP) Price Target to $73 00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesNikhil lalwaniMuthusamy shanmugamFinancial services group incPharmaceuticals dailyAni pharmaceuticalsMetlife investment managementPharmaceuticals incPharmaceuticals trading downCitigroup incSwiss national bankFree reportModerate buyTrading downGet free reportNational bank

ANI Pharmaceuticals (NASDAQ:ANIP) Updates FY 2023 Earnings Guidance

ANI Pharmaceuticals (NASDAQ:ANIP) Updates FY 2023 Earnings Guidance
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesNova scotiaMuthusamy shanmugamNikhil lalwaniSecurities exchange commissionPharmaceuticals stock downAni pharmaceuticalsPharmaceuticals company profilePharmaceuticals dailyVanguard group incPharmaceuticals incGeode capital managementDimensional fund advisorsBlackrock incGet free reportModerate buy